SPORANOX

This brand name is authorized in Austria, Australia, Brazil, Canada, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Malta, Mexico, New Zealand, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SPORANOX contains one active pharmaceutical ingredient (API):

1 Itraconazole UNII 304NUG5GF4 - ITRACONAZOLE

Itraconazole is a triazole derivative that inhibits fungal 14α-demethylase, resulting in a depletion of ergosterol and disruption of membrane synthesis by fungi. Read about Itraconazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SPORANOX I.V. Concentrate and solvent for solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J02AC02	Itraconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8196J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514504501110312, 514504502117310, 514504503113319, 514504504111311
Country: CA	Health Products and Food Branch	Identifier(s): 02047454, 02231347
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59343
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 148882, 153494, 155648, 505628, 524330
Country: FR	Base de données publique des médicaments	Identifier(s): 62469613, 69998156
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143878, 200277, 23854, 23859, 23860, 23869, 381678
Country: HK	Department of Health Drug Office	Identifier(s): 43776, 51056
Country: IE	Health Products Regulatory Authority	Identifier(s): 61411, 61441, 61455, 61480, 71278
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4187
Country: IT	Agenzia del Farmaco	Identifier(s): 027808017
Country: MT	Medicines Authority	Identifier(s): AA565/03402
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 214M87
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4323
Country: SG	Health Sciences Authority	Identifier(s): 08206P, 09823P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593595165
Country: US	FDA, National Drug Code	Identifier(s): 50458-290, 50458-295
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/20.2.2/0429, W/20.2.2/43